Neurocrine Biosciences (NBIX) Tops Q2 EPS by 1c
Tweet
Share
E-mailGet Alerts NBIX Hot Sheet
Price: $138.97 --0%
Revenue Growth %: +25.6%
Financial Fact:
Total operating expenses: 38.44M
Today's EPS Names:
UXIN, TOWN, NRIM, More
Revenue Growth %: +25.6%
Financial Fact:
Total operating expenses: 38.44M
Today's EPS Names:
UXIN, TOWN, NRIM, More
Join SI Premium – FREE
Neurocrine Biosciences (NASDAQ: NBIX) reported Q2 EPS of ($0.28), $0.01 better than the analyst estimate of ($0.29).
For earnings history and earnings-related data on Neurocrine Biosciences (NBIX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Wells Fargo Upgrades Neurocrine Bio. (NBIX) to Overweight 'as the Company is Knocking on the Doors of the Large-Cap Club'
- Honeywell (HON) Tops Q1 EPS by 8c, Beats on Revenue; Offers FY Guidance
- Meta shares dip on softer Q2 revenue guidance, elevated AI spending plans
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
